Literature DB >> 11478677

Flagellin gene PCR-RFLP analysis of a panel of strains from the Burkholderia cepacia complex.

Craig Winstanley1, Maria G Detsika1, Kerry J Glendinning1, Yasmin N Parsons1, C Anthony Hart1.   

Abstract

Burkholderia cepacia, an important opportunist pathogen, is genetically heterogeneous. The B. cepacia complex has been subdivided into a number of genospecies or genomovars. A flagellin gene PCR-RFLP method was applied to a representative panel of strains of known genomovar. The technique was able to distinguish strains of B. multivorans from other members of the B. cepacia complex on the basis of amplicon size (typical of type I rather than type II flagellins) with the exception of one genomovar I strain. There was considerable variation in RFLP patterns amongst the panel of strains; only two pairs of strains were indistinguishable with both HaeIII and MspI digestion. Where RFLP patterns matched with both enzymes or a single enzyme, matching strains were always in the same genomovar. It was possible to distinguish the UK cystic fibrosis epidemic strain from all other members of the panel, including nine other genomovar III strains. The level of variation suggests that flagellin genotyping is a useful method for discriminating between B. cepacia strains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478677     DOI: 10.1099/0022-1317-50-8-728

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.

Authors:  Maria G Detsika; John E Corkill; Marcelo Magalhães; Kerry J Glendinning; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom.

Authors:  Jane F Turton; Mary E Kaufmann; Nazim Mustafa; Sonia Kawa; Fiona E Clode; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.